Literature DB >> 202694

Purinergic inhibition of adrenergic transmission in rabbit blood vessels.

C Su.   

Abstract

The effect of ATP and its congeners on the adrenergic neuroeffector transmission was evaluated in isolated blood vessels of the rabbit. ATP, ADP, AMP and adenosine inhibited the contractile response of the portal vein to adrenergic nerve stimulation, with a threshold concentration of the order of 0.1 muM and ED50 of about 1 microM. These agents, but not papaverine, inhibited the nerve stimulation-induced response in preference to the norepinephrine- or serotonin-induced response in the portal and saphenous veins and pulmonary and ear arteries. In the portal vein labeled with [3H]norepinephrine, ATP diminished the nerve stimulation-induced efflux of tritiated material. This nucleotide also reduced the KCl-induced tritium efflux but not the tyramine induced-efflux in the [3H]norepinephrine-labeled thoracic aorta. ATP had no significant effect on the uptake of [3H]norepinephrine in the portal vein, ear artery and thoracic aorta. Indomethacin and theophylline partially blocked the inhibitory action of ATP on the neurogenic constrictor response in some of the ear artery and saphenous vein preparations. Desipramine, atropine, propanolol, haloperidol and 2,2'-pyridylisatogen, a blocking agent against ATP in the taenia coli, were without such antagonistic effect. The results are consistent with a proposed negative feedback modulator role of ATP or a related purine compound in adrenergic transmission.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 202694

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  25 in total

1.  Pre- and post-junctional effects of adenosine triphosphate on noradrenergic transmission in the rabbit ear artery.

Authors:  H Miyahara; H Suzuki
Journal:  J Physiol       Date:  1987-08       Impact factor: 5.182

2.  Responses of blood vessels in the rabbit knee to electrical stimulation of the joint capsule.

Authors:  W R Ferrell; A Khoshbaten
Journal:  J Physiol       Date:  1990-04       Impact factor: 5.182

3.  Presynaptic inhibitory actions of 2-substituted adenosine derivatives on neurotransmission in rat vas deferens: effects of inhibitors of adenosine uptake and deamination.

Authors:  M J Muller; D M Paton
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-01       Impact factor: 3.000

4.  Intracranial pressure changes during infusions of adenosine triphosphate and sodium nitroprusside.

Authors:  S Thiagarajah; I Azar; E Lear; E M Machetnis
Journal:  Bull N Y Acad Med       Date:  1987-03

5.  Potentiation of the effects of adenosine on isolated cardiac and smooth muscle by diazepam.

Authors:  A S Clanachan; R J Marshall
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

6.  Indirect evidence that purinergic modulation of perivascular adrenergic neurotransmission in the portal vein is a physiological process.

Authors:  G Burnstock; R Crowe; C Kennedy; J Török
Journal:  Br J Pharmacol       Date:  1984-06       Impact factor: 8.739

7.  Pharmacological characterization of adenosine A1 and A2 receptors in the bladder: evidence for a modulatory adenosine tone regulating non-adrenergic non-cholinergic neurotransmission.

Authors:  C G Acevedo; E Contreras; J Escalona; J Lewin; J P Huidobro-Toro
Journal:  Br J Pharmacol       Date:  1992-09       Impact factor: 8.739

8.  Adenosine receptors mediate a pertussis toxin-insensitive prejunctional inhibition of noradrenaline release on a papillary muscle model.

Authors:  W Schütz; M Ströher; M Freissmuth; B Valenta; E A Singer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-03       Impact factor: 3.000

9.  Studies on secretion of catecholamines evoked by acetylcholine or transmural stimulation of the rat adrenal gland.

Authors:  A R Wakade
Journal:  J Physiol       Date:  1981       Impact factor: 5.182

10.  Release of purines and noradrenaline by ouabain and potassium chloride from vascular adrenergic nerves.

Authors:  T Katsuragi; C Su
Journal:  Br J Pharmacol       Date:  1982-12       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.